These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27623022)

  • 61. Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.
    Lebedinsky C; Gómez J; Park YC; Nieto A; Soto-Matos A; Parekh T; Alfaro V; Roy E; Lardelli P; Kahatt C
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1223-31. PubMed ID: 21416137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
    Cuevas C; Francesch A
    Nat Prod Rep; 2009 Mar; 26(3):322-37. PubMed ID: 19240944
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current trends of benzothiazoles in drug discovery: a patent review (2015-2020).
    Law CSW; Yeong KY
    Expert Opin Ther Pat; 2022 Mar; 32(3):299-315. PubMed ID: 34986720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A patent review of two fruitful decades (1997-2016) of Isocoumarin research.
    Hussain H; Green IR
    Expert Opin Ther Pat; 2017 Nov; 27(11):1267-1275. PubMed ID: 28621561
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).
    Collina S; Bignardi E; Rui M; Rossi D; Gaggeri R; Zamagni A; Cortesi M; Tesei A
    Expert Opin Ther Pat; 2017 May; 27(5):565-578. PubMed ID: 28051882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endogenous Synthesis of Tetrahydroisoquinoline Derivatives from Dietary Factors: Neurotoxicity Assessment on a 3D Neurosphere Culture.
    Aro R; Nachtergael A; Palmieri C; Ris L; Duez P
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biosynthesis of Tetrahydroisoquinoline Antibiotics.
    Tang GL; Tang MC; Song LQ; Zhang Y
    Curr Top Med Chem; 2016; 16(15):1717-26. PubMed ID: 26456466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids.
    Pyne ME; Kevvai K; Grewal PS; Narcross L; Choi B; Bourgeois L; Dueber JE; Martin VJJ
    Nat Commun; 2020 Jul; 11(1):3337. PubMed ID: 32620756
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).
    Xiu C; Hua Z; Xiao BS; Tang WJ; Zhou HP; Liu XH
    Expert Opin Ther Pat; 2017 Sep; 27(9):1031-1045. PubMed ID: 28627270
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic potential of seabuckthorn: a patent review (2000-2018).
    Singh IP; Ahmad F; Gore DD; Tikoo K; Bansal A; Jachak SM; Jena G
    Expert Opin Ther Pat; 2019 Sep; 29(9):733-744. PubMed ID: 31340664
    [No Abstract]   [Full Text] [Related]  

  • 72. MYC modulators in cancer: a patent review.
    Wang XN; Su XX; Cheng SQ; Sun ZY; Huang ZS; Ou TM
    Expert Opin Ther Pat; 2019 May; 29(5):353-367. PubMed ID: 31068032
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cucurbitacins as Anticancer Agents: A Patent Review.
    Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
    Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Asymmetric Synthesis of Fused-Ring Tetrahydroisoquinolines and Tetrahydro-β-carbolines from 2-Arylethylamines via a Chemoenzymatic Approach.
    Yang L; Li J; Xu Z; Yao P; Wu Q; Zhu D; Ma Y
    Org Lett; 2022 Sep; 24(36):6531-6536. PubMed ID: 36066397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. QSAR modelling: a therapeutic patent review 2010-present.
    Halder AK; Moura AS; Cordeiro MNDS
    Expert Opin Ther Pat; 2018 Jun; 28(6):467-476. PubMed ID: 29745270
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patent Survey of Resveratrol, Taxol, Podophyllotoxin, Withanolides and Their Derivatives Used in Anticancer Therapy.
    Routh S; Nandagopal K
    Recent Pat Biotechnol; 2017; 11(2):85-100. PubMed ID: 28137207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of radio-sensitization patents in China from 2006 to 2015.
    He G; Di X; Sun X; Yan J; Zhang S
    Expert Opin Ther Pat; 2017 Oct; 27(10):1159-1172. PubMed ID: 28621575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. On-DNA Cross-Dehydrogenative Coupling Reaction toward the Synthesis of Focused DNA-Encoded Tetrahydroisoquinoline Libraries.
    Wen X; Duan Z; Liu J; Lu W; Lu X
    Org Lett; 2020 Aug; 22(15):5721-5725. PubMed ID: 32644810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PM00104 (Zalypsis®): a marine derived alkylating agent.
    Petek BJ; Jones RL
    Molecules; 2014 Aug; 19(8):12328-35. PubMed ID: 25153860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Probing into Therapeutic Anti-cancer Potential of Apigenin: Recent Trends and Future Directions.
    Sharma A; Ghani A; Sak K; Tuli HS; Sharma AK; Setzer WN; Sharma S; Das AK
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):124-133. PubMed ID: 31418666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.